Cost-Effectiveness of Transcranial Magnetic Stimulation for Methamphetamine Use Disorder during Pregnancy.
Limited data exist on the safety of TMS and injectable naltrexone with bupropion for fetuses and infants. Future research is crucial to update this model, confirm safety and efficacy, and explore perinatal outcomes for MUD in pregnancy, ensuring optimal care for this population.
Authors
- Brian J. Mickey (ORCID: https://orcid.org/0000-0002-7847-7680)
- Rana Jawish (ORCID: https://orcid.org/0009-0002-9053-8156)
- Adam J. Gordon
- A Tawfik
- Marcela C. Smid
- Robert Silver
- Casey R Tak
Institutions
- University of Utah (US)
Publication Details
- Journal
- PubMed
- Published
- 2025-12-01
- Primary Topic
- Prenatal Substance Exposure Effects
- Type
- article
- Field-Weighted Citation Impact
- 0.00